Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma
Clinical trial NCT06919939 · RECRUITING
Trial details
- NCT number
- NCT06919939
- Sponsor
- University of Miami
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-07
- Primary completion
- 2031-01-07
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.